Is generative pre-trained transformer artificial intelligence (Chat-GPT) a reliable tool for guidelines synthesis? A preliminary evaluation for biologic CRSwNP therapy

Banoub RG, Hoehle LP, Phillips KM et al (2018) Depressed Mood Modulates Impact of Chronic Rhinosinusitis Symptoms on Quality of Life. J Allergy Clin Immunol Pract 6(6):2098–2105. https://doi.org/10.1016/j.jaip.2018.04.034

Article  PubMed  Google Scholar 

De Corso E, Pipolo C, Cantone E et al (2022) Survey on use of local and systemic corticosteroids in the management of chronic rhinosinusitis with nasal polyps: identification of unmet clinical needs. J Pers Med 12(6):897. https://doi.org/10.3390/jpm120608972

Article  PubMed  PubMed Central  Google Scholar 

Rank MA, Chu DK, Bognanni A, Oykhman P, Bernstein JA, Ellis AK, Golden DBK, Greenhawt M, Horner CC, Ledford DK, Lieberman J, Luong AU, Orlandi RR, Samant SA, Shaker MS, Soler ZM, Stevens WW, Stukus DR, Wang J, Peters AT (2023) The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol 151(2):386–398. https://doi.org/10.1016/j.jaci.2022.10.026

Article  PubMed  Google Scholar 

Haxel BR, Hummel T, Fruth K et al (2022) Real-world-effectiveness of biological treatment for severe chronic rhinosinusitis with nasal polyps. Rhinology 60(6):435–443. https://doi.org/10.4193/Rhin22.129

Article  CAS  PubMed  Google Scholar 

La Mantia I, Grigaliute E, Ragusa M, Cocuzza S, Radulesco T, Saibene AM, Calvo-Henriquez C, Fakhry N, Michel J, Maniaci A (2023) Effectiveness and rapidity on olfatory fuction recovery in CRS patients treated with Dupilumab: a real life prospective controlled study. Eur Arch Otorhinolaryngol. https://doi.org/10.1007/s00405-023-08184-6

Article  PubMed  PubMed Central  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 29(372):n71. https://doi.org/10.1136/bmj.n71

Article  Google Scholar 

Yang SK, Cho SH, Kim DW (2022) Interpretation of clinical efficacy of biologics in chronic rhinosinusitis with nasal polyps via understanding the local and systemic pathomechanisms. Allergy Asthma Immunol Res 14(5):465–478. https://doi.org/10.4168/aair.2022.14.5.465

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bachert C, Zhang N, Cavaliere C, Weiping W, Gevaert E, Krysko O (2020) Biologics for chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 145(3):725–739. https://doi.org/10.1016/j.jaci.2020.01.020

Article  CAS  PubMed  Google Scholar 

Bachert C, Han JK, Wagenmann M, Hosemann W, Lee SE, Backer V, Mullol J, Gevaert P, Klimek L, Prokopakis E, Knill A, Cavaliere C, Hopkins C, Hellings P (2021) EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management. J Allergy Clin Immunol 147(1):29–36. https://doi.org/10.1016/j.jaci.2020.11.013

Article  CAS  PubMed  Google Scholar 

Fokkens WJ, Lund V, Bachert C, Mullol J, Bjermer L, Bousquet J, Canonica GW, Deneyer L, Desrosiers M, Diamant Z, Han J, Heffler E, Hopkins C, Jankowski R, Joos G, Knill A, Lee J, Lee SE, Mariën G, Pugin B, Senior B, Seys SF, Hellings PW (2019) EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy 74(12):2312–2319. https://doi.org/10.1111/all.13875

Article  PubMed  Google Scholar 

Fokkens WJ, Viskens AS, Backer V, Conti D, De Corso E, Gevaert P, Scadding GK, Wagemann M, Bernal-Sprekelsen M, Chaker A, Heffler E, Han JK, Van Staeyen E, Hopkins C, Mullol J, Peters A, Reitsma S, Senior BA, Hellings PW (2023) EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023. Rhinology. https://doi.org/10.4193/Rhin22.489

Article  PubMed  Google Scholar 

Maza-Solano J, Biadsee A, Sowerby LJ, Calvo-Hernández C, Tucciarone M, Rocha T, Maniaci A, Saibene AM, Chiesa-Estomba CM, Radulesco T, Metwaly O, Lechien JR, Alobid I, Locatello LG (2023) Chronic rhinosinusitis with nasal polyps management in the biologic therapy era: an international YO-IFOS survey. Eur Arch Otorhinolaryngol 280(5):2309–2316. https://doi.org/10.1007/s00405-022-07762-4

Article  PubMed  Google Scholar 

Rampi A, Vinciguerra A, Tanzini U, Bussi M, Trimarchi M (2023) Comparison of guidelines for prescription and follow-up of biologics for chronic rhinosinusitis with nasal polyps. Eur Arch Otorhinolaryngol 280(1):39–46. https://doi.org/10.1007/s00405-022-07634-x

Article  PubMed  Google Scholar 

Agache I, Song Y, Alonso-Coello P, Vogel Y, Rocha C, Solà I, Santero M, Akdis CA, Akdis M, Canonica GW, Chivato T, Del Giacco S, Eiwegger T, Fokkens W, Georgalas C, Gevaert P, Hopkins C, Klimek L, Lund V, Naclerio R, O’Mahony L, Palkonen S, Pfaar O, Schwarze J, Soyka MB, Wang Y, Zhang L, Canelo-Aybar C, Palomares O, Jutel M (2021) Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines. Allergy 76(8):2337–2353. https://doi.org/10.1111/all.14809

Article  CAS  PubMed  Google Scholar 

Hopkins C, McKenzie JL, Anari S, Carrie S, Ramakrishnan Y, Kara N, Philpott C, Hobson J, Qureishi A, Stew B, Bhalla R, Gane S, Walker A, Harries P, Hathorn I, Lund V (2021) British Rhinological Society Consensus Guidance on the use of biological therapies for chronic rhinosinusitis with nasal polyps. Clin Otolaryngol 46(5):1037–1043. https://doi.org/10.1111/coa.13779

Article  PubMed  Google Scholar 

Al-Ahmad M, Alsaleh S, Al-Reefy H, Al Abduwani J, Nasr I, Al Abri R, Alamadi AMH, Fraihat AA, Alterki A, Abuzakouk M, Marglani O, Rand HA (2022) Expert Opinion on Biological Treatment of Chronic Rhinosinusitis with Nasal Polyps in the Gulf Region. J Asthma Allergy 4(15):1–12. https://doi.org/10.2147/JAA.S321017

Article  Google Scholar 

Scadding GK, Scadding GW (2022) Biologics for chronic rhinosinusitis with nasal polyps (CRSwNP) J Allergy Clin Immunol;49(3):895–897. doi: https://doi.org/10.1016/j.jaci.2021.10.029.

Tversky J, Lane AP, Azar A (2021) Benralizumab effect on severe chronic rhinosinusitis with nasal polyps (CRSwNP): A randomized double-blind placebo-controlled trial. Clin Exp Allergy 51(6):836–844. https://doi.org/10.1111/cea.13852

Article  CAS  PubMed  Google Scholar 

Bachert C, Han JK, Desrosiers MY et al (2022) Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial. J Allergy Clin Immunol 149(4):1309-1317.e12. https://doi.org/10.1016/j.jaci.2021.08.030

Article  CAS  PubMed  Google Scholar 

Takabayashi T, Asaka D, Okamoto Y et al (2021) A Phase II, Multicenter, Randomized, Placebo-Controlled Study of Benralizumab, a Humanized Anti-IL-5R Alpha Monoclonal Antibody, in Patients With Eosinophilic Chronic Rhinosinusitis. Am J Rhinol Allergy 35(6):861–870. https://doi.org/10.1177/19458924211009429

Article  PubMed  Google Scholar 

Canonica GW, Harrison TW, Chanez P et al (2022) Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis. Allergy 77(1):150–161. https://doi.org/10.1111/all.14902

Article  CAS  PubMed  Google Scholar 

Weinstein SF, Katial RK, Bardin P et al (2019) Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps. J Allergy Clin Immunol Pract 7(2):589-596.e3. https://doi.org/10.1016/j.jaip.2018.08.021

Article  PubMed  Google Scholar 

Wong G, Greenhalgh T, Westhorp G, Pawson R (2014) Development of methodological guidance, publication standards and training materials for realist and meta-narrative reviews: the RAMESES (Realist And Meta-narrative Evidence Syntheses – Evolving Standards) project. Southampton (UK): NIHR Journals Library

Lechien JR, Maniaci A, Gengler I, Hans S, Chiesa-Estomba CM, Vaira LA (2023) Validity and reliability of an instrument evaluating the performance of intelligent chatbot: the Artificial Intelligence Performance Instrument (AIPI). Eur Arch Otorhinolaryngol. https://doi.org/10.1007/s00405-023-08219-y

Article  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif